|
|
|
| home > ict > Summer 2018 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
|
 |
| |
|
|
|
|
|
Regulatory Guidance on Outsourcing
Organising Outsourcing
Martin Robinson at IAOCR delves into the world of outsourcing as a part of clinical trials and provides a detailed account of how to receive advice and guidance through regulatory bodies.
|
|
|
|
Dealing with Data Protection
Protecting Privacy
ICT spoke to Dr Andrew Rut at MyMeds&Me to discuss the all-important topic of patient data safety during clinical trials and the ways in which this sensitive issue should be approached.
|
|
|
|
|
Q&A: Clinical Trial Transparency
Patient Privacy
ICT spoke to Thomas Wicks and Francine Lane at TrialScope about noncompliance, the risks and penalties it can lead to, and how to avoid running afoul of regulators.
|
|
|
|
|
Improving the Clinical Trial Continuum
Perfecting Practices
Investments in new technologies to increase performances, gain greater quality, and encourage optimisation across trials are some of the most pressing topics for companies. Craig Morgan at goBalto provides an insight.
|
|
|
|
|
Event Preview
Let’s Get Clinical
Get a taste of what to expect in this event preview if visiting Partnerships in Clinical Trials Europe this November, including one-to-one meetings, digital partnering, and networking with industry leaders from around the globe.
|
|
|
|
|
|
Using Gamification and Behavioural Economics in Surveys
Gaining from Gamification
Creating a questionnaire for clinical trials can be fraught with difficulties, particularly when attempting to extract as much data as possible from respondents. Dr Keith Meadows at Health Outcome Solutions provides a clearer answer.
|
|
|
|
Translation and Comprehension of Disease Activity
PRO Translation
Language barriers and translation issues when using patient-recorded outcomes over a multinational patient group are an essential consideration. The team at RWS Life Sciences tell us more.
|
|
|
|
Site Engagement Technology
Appreciated and Informed
Using different scenarios to promote the use of site engagement technology, Dani Darasz and Lesley Freese at DrugDev comment on how clean trial data and protocol adherence can be greatly improved.
|
|
|
|
|
|
Q&A: Partnerships in Clinical Trials Europe
Clinical Connections
With the upcoming Partnerships in Clinical Trials Europe event in November quickly approaching, ICT spoke to Louisa Maitland about what visitors can expect from the main streams.
|
|
|
|
|
Robust Insurance Policies
Navigating Global Complexities
Kathryn Moon at Gallagher sheds some light on key insurance considerations, as deciding on a specific insurance policy can be one of the great difficulties a company faces when conducting clinical trials.
|
|
|
|
Clinical Trials Liability Insurance
A Safety Net
Designed to excel if issues arise during any clinical trial, insurance is an essential and continuously evolving entity. Hanna Beaumont at La Playa explains some of the associated complexities in the industry.
|
|
|
|
|
|
Current Trends in Outsourcing
Outsourcing Evolution
Outsourcing has been ongoing in the pharmaceutical industry for many years, but, as the methods develop, which is the right approach? Colin Stanley at ICON Functional Services explains.
|
|
|
|
Functional Outsourcing Versus Full-Service Partnerships
Strategic Selection
Jeff Mayhew and Elizabeth Koury at LabConnect describe the top factors that companies should examine when selecting a strategic partner for assistance in clinical trials.
|
|
|
|
|
End Point
Restricting Remedies
ICT’s Editor Dr Graham Hughes surveys the differing regulations regarding cannabis between the US and UK.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms
Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >> |
|
 |
White Papers |
 |
|
Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery
Presspart Manufacturing Ltd
Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >> |
|
 |
Industry Events |
 |
Nordic Life Science Days 10/12 September 2019
10-12 September 2019, Malmo Sweden
Nordic Life Science Days is the largest Nordic partnering conference for the global Life
Science industry.
Bringing together the best talents in Life Science, offering amazing networking and
partnering opportunities, providing inputs and content on the most recent trends.
Nordic Life Science Days attracts leading decision makers from the Life Science sector,
not only from biotech, pharma and medtech but also from finances, research, policy and
regulatory authorities.
More info >> |
|
|
